ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SAN Sanofi

87.89
-0.95 (-1.07%)
Feb 29 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Sanofi SAN Euronext Ordinary Share
  Price Change Change Percent Stock Price Last Traded
-0.95 -1.07% 87.89 11:40:00
Open Price Low Price High Price Close Price Prev Close
88.61 87.88 89.23 87.89 88.84
more quote information »

Recent News

Date Time Source Heading
2/24/202409:51GLOBECommuniqué : Résultats de phase II montrent que le..
2/23/202412:45GLOBECommuniqué de presse : Dépôt du Document d’Enregistrement..
2/23/202401:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
2/22/202413:02GLOBECommuniqué de presse : Le Conseil d’administration de Sanofi..
2/20/202417:40GLOBESanofi: Information concerning the total number of voting..
2/16/202401:00GLOBEPress Release: Japan first in the world to approve Dupixent®..
2/15/202408:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
2/05/202402:00GLOBECommuniqué de presse : Entraide, conditions de travail..
2/01/202401:30GLOBECommuniqué de presse : François-Xavier Roger nommé Directeur..
1/25/202414:30GLOBECommuniqué de presse : Dupixent® : premier et seul..
1/23/202406:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
1/23/202401:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
1/17/202416:57GLOBESanofi: Information concerning the total number of voting..
1/09/202402:14DJNSanofi Names Brian Foard Head of Specialty-Care Unit
1/09/202401:30GLOBECommuniqué de presse : Brian Foard est nommé Responsable de..
12/21/202302:25DJNSanofi Ends Drug Program After Late-Stage Trial in Lung..
12/21/202301:30GLOBEPress Release: Sanofi announces end of program evaluating..
12/19/202307:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
12/18/202315:59GLOBESanofi: Information concerning the total number of voting..
12/15/202301:30GLOBECommuniqué de presse : Mise en ligne du document «Q4 2023..
12/15/202301:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
12/11/202317:18DJNSanofi Terminates Agreement with Maze Therapeutics Following..
12/11/202316:08GLOBEPress Release: Statement on FTC challenge to proposed..
12/11/202301:50DJNSanofi Sees Improvement in Trial Results of Cancer Drug..
12/10/202319:30GLOBECP : Sarclisa® (isatuximab) plus KRd améliore..
12/07/202302:34DJNSanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage..
12/07/202302:20DJNSanofi Sees Annual Sales From New Pharma Assets Above $10.8..
12/07/202301:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
12/06/202321:30GLOBECommuniqué de presse : Sanofi sur la voie du leadership..
12/06/202308:20DJNTrending: Merck's Multiple Sclerosis Drug Misses..
12/06/202305:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
11/30/202309:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
11/27/202310:31DJNTrending: Sanofi's Notus Trial Meets Primary Endpoint
11/27/202302:40DJNSanofi Says Notus Phase 3 Trial of Dupixent Met Primary..
11/27/202301:30GLOBEDupixent® (dupilumab) Significantly Reduced COPD..
11/23/202312:00GLOBESanofi: Information concerning the total number of voting..
11/07/202308:56DJNSanofi Under Preliminary Probe in France Over Possible..
10/30/202308:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
10/27/202311:47DJNSanofi Down Over 19%, on Pace for Record Percent Decrease --..
10/27/202304:43DJNSanofi Shares Tumble After Warning of Profit Hit From..
10/27/202302:54DJNSanofi Backs Guidance After Earnings, Sales Miss Views
10/27/202302:35DJNSanofi Plans to Split Consumer-Healthcare, Pharma Businesses..
10/27/202302:07DJNSanofi Plans to Spin Off Consumer-Healthcare Business
10/27/202301:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
10/27/202301:30GLOBECommuniqué de presse : Sanofi entame un nouveau chapitre de..
10/22/202315:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 Results show..
10/22/202314:59GLOBEDupixent® (dupilumab) Phase 3 Results Show Sustained..
10/19/202306:00GLOBECommuniqué de presse : Sanofi livre les premiers médicaments..
10/18/202305:40DJNSanofi Says Drug Shows Potential to Slow Diabetes in..
10/18/202304:45GLOBEPress Release: TZIELD® Phase 3 data presented at ISPAD shows..

Your Recent History

Delayed Upgrade Clock